Roche aims for 11 immunotherapy cancer drugs in late-stage trials this year

BASEL, April 13 (Reuters) - Roche aims to have 11 immunotherapy cancer drugs in late-stage trials by the end of the year, the Swiss drugmaker's head of medical affairs for oncology, Nico Andre, said at a conference on Monday.